Health Care: Drugs

OxiGene Inc (OXGN: NASDAQ)

$0.945 0.045 | 5%
11/25/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 0.95
52 Week High 1.97
52 Week Low 0.78
Avg. Daily Vol. (Mil) 0.23
Beta (3 year) 0.88
Share Related Items
Mkt Cap (Mil) 25.08
Shares Out (Mil) 26.54
Float (Mil) 26.52
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 28.40
Current Ratio 28.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 0.00
Price/Book 0.77
Price/Cash Flow -2.10
Per Share Data
Earnings -0.53
Sales 0.00
Book Value 1.22
Cash Flow -0.46
Business Summary
OxiGene Inc is a biopharmaceutical company. The Company is engaged in development of vascular disrupting agents (VDAs) for the treatment of cancer. It has two clinical stage product candidates that are developed in three potential oncology indications.
General Information
701 Gateway Boulevard
Suite 210
South San Francisc, CA 94080
Industry : Drugs
Sector: Health Care
Employees: 13
CEO: Dr. William D. Schwieter
Short Interest
Current Month (Mil) 1.48
Previous Month (Mil) 1.59
Short Interest Ratio (Days) 7.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -36.20
Return on Investments -37.50
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with OXGN

Latest OXGN Headlines from TheStreet

More Financial News for OXGN

Press Releases for OXGN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter